Ambit proposes IPO

Ambit Biosciences Corp., San Diego, Calif. Business: Cancer, Autoimmune, Inflammation Date announced: 2/20/13 Type: IPO Shares: TBD Price: TBD To be raised: Up to $57.5 million Underwriters: Citigroup...